Agilent Renews Focus on Separations, Hopes To Lead HPLC Consumables Market by 2010 | GenomeWeb
With the launch of its 1200 Rapid Resolution liquid chromatographer last year, Agilent Technologies now has its sights on conquering the separations space.
 
Nick Roelofs, general manager of life sciences at Agilent, told ProteoMonitor that concurrent with its plan to continue building its mass spectrometry business, Agilent will look to foment its separations business as part of the company’s still-developing proteomics strategy.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.